Kenneth Ying-Kit Lo

Dr. Kenneth Lo practices law in the area of pharmaceuticals, biotechnology, chemistry and consumer products. He has extensive experience with Hatch-Waxman and FDA issues from a generic and brand pharmaceutical perspective, which he acquired during his more than 10 years as in-house counsel at Ranbaxy Inc., Takeda Pharmaceuticals North America and Forest Laboratories.

Kenneth managed and strategically implemented IP portfolios for several major global pharmaceutical corporations. He has prepared and prosecuted numerous patent applications worldwide, conducted numerous due diligence reviews and related negotiations that resulted in several multi-million dollar transactions, and managed several high-profile foreign and domestic litigations directed to blockbuster pharmaceuticals, including to Lipitor®, Nexium® and Valcyte®, as well as a data exclusivity challenge in Canada for Dexilant®.

Kenneth received a Bachelor of Science degree in Chemistry from the University of Victoria, a Ph.D. in Chemistry from the University of Florida and a J.D. from the Washington College of Law, American University.  In addition, Kenneth spent one year at Duke University as a postdoctoral research associate in the Department of Chemistry and Department of Cardiology.  He is licensed to practice in Maryland, New Jersey, and the U.S. Patent and Trademark Office.